Target intelligence / Profile preview

Glucan endo-1,3-beta-D-glucosidase (Beta-glucanase)

Target
Beta-glucanase
Molecular classification
Enzyme, Glycoside hydrolase
01

Overview

Beta-glucanases are a diverse group of glycoside hydrolase enzymes responsible for the degradation of beta-glucans, which are essential structural polysaccharides in the cell walls of fungi, plants, and certain bacteria. In fungi, these enzymes play critical roles in cell wall remodeling, morphogenesis, and hyphal branching, which are vital for the survival and pathogenicity of organisms like Candida albicans and Aspergillus fumigatus. Due to their absence in the human genome, fungal beta-glucanases, particularly the exo-1,3-beta-glucanase isoform, represent promising therapeutic targets for the development of selective antifungal agents. Conversely, beta-glucanase is also employed as a therapeutic drug or dietary supplement in humans to facilitate the digestion of complex fibers and to disrupt resistant fungal biofilms. In clinical diagnostics, the presence of the enzyme's substrate, (1,3)-beta-D-glucan, serves as a significant biomarker for invasive fungal infections. Beyond medicine, these enzymes are extensively used in the food and beverage industry to reduce the viscosity of grain-based products and enhance nutrient absorption in animal feed. Research into small-molecule inhibitors, such as sesamin, continues to explore their potential in overcoming resistance to current antifungal treatments like azoles and polyenes.

Other names
LaminarinaseEndo-1,3-beta-glucanaseExo-1,3-beta-glucanaseBeta-1,3-glucanaseCallaseLaminaranaseOligo-1,3-glucosidase
02

Mechanism of action

Hydrolysis of internal or terminal beta-1,3-glycosidic bonds in beta-glucan polysaccharides to soften or degrade cell walls.

03

Biological functions

Cell wall remodelingCarbohydrate metabolismPolysaccharide degradationInnate immune response (in plants)Fungal morphogenesisBiofilm disruption
04

Disease associations

Fungal infectionCandidiasisAspergillosisGastrointestinal disordersMetabolic syndrome
05

Safety considerations

Gastrointestinal distress (with oral supplements)Potential for allergic reactionsTherapeutic challenge of specificity in cross-species inhibition
06

Interacting drugs

Sesamin
07

Biomarkers

(1,3)-beta-D-glucan (BDG)

Beyond the preview

Go deeper on Glucan endo-1,3-beta-D-glucosidase (Beta-glucanase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glucan endo-1,3-beta-D-glucosidase (Beta-glucanase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call